You can help find new cures for kids with cancer
“Clinical trials have improved childhood cancer survival from 20% to 80% over the last 50 years.”
~ Dr. Greg Guilcher, Alberta Children’s Hospital
OUR COMMITMENT
With your support, by 2027, Kids Cancer Care will invest $2.5 million in children’s cancer research and clinical trials at the Alberta Children’s Hospital and University of Calgary.
This investment will
1. Improve access to clinical trials for children with high-risk cancers;
2. Fund two post-doctoral research fellowships;
3. Support psycho-social research; and
4. Provide granting competitions for researchers.
THE NEED
Clinical trials are essential to advancing research and treatment protocols, but unlike adult cancer trials, children’s cancer trials must rely heavily on philanthropy. Although it takes an enormous toll, childhood cancer is a rare disease and offers drug and biotechnology companies little potential for return on investment. And yet, clinical trials are a critical step in developing new therapies that save young lives.
“The weakest link in research for childhood cancer drugs, and the greatest threat to continued improvement in outcomes for children with cancer is pediatric drug discovery.”
— Dr. Peter C. Adamson, Global Head, Oncology Development & Pediatric Innovation, Sanofi
Only 7% of Canada’s cancer research funding goes to children’s cancer research. With your support, Kids Cancer Care is helping to change this. Your support will help the PHOENIX team at the Alberta Children’s Hospital and University of Calgary double the number of pediatric cancer clinical trials available for children.
The children who will most benefit from new trials and novel therapies are those battling
1. Rare cancers with no standard treatments;
2. Cancers that have spread or recurred; and
3. Cancers with a poor prognosis at diagnosis.
The PHOENIX team envisions a future where every child in need of a new therapy or clinical trial can access one.
Thank you for supporting our vision.